A 69-year old male Barrett’s esophagus (BE) patient arrived at Dr. Tseng’s practice after moving to Oregon from another state. The patient was anxious about his BE, but that concern is common for many BE patients who know that they have a precancerous condition and feel uncertain about their risk of developing cancer.
Read the case details below.
A 69-year old male Barrett’s esophagus (BE) patient arrived at Dr. Tseng’s practice after moving to Oregon from another state. The patient was anxious about his BE, but that concern is common for many BE patients who know that they have a precancerous condition and feel uncertain about their risk of developing cancer.
Read the case details below.
A 69-year old male Barrett’s esophagus (BE) patient arrived at Dr. Tseng’s practice after moving to Oregon from another state. The patient was anxious about his BE, but that concern is common for many BE patients who know that they have a precancerous condition and feel uncertain about their risk of developing cancer.
Read the case details below.
A 69-year old male Barrett’s esophagus (BE) patient arrived at Dr. Tseng’s practice after moving to Oregon from another state. The patient was anxious about his BE, but that concern is common for many BE patients who know that they have a precancerous condition and feel uncertain about their risk of developing cancer.
Read the case details below.
The 69-year-old male BE patient presented to Dr. Tseng with mixed clinical risk factors. He had no relevant family history, but was obese with chronic GERD and a history of smoking. He was aware he had BE.
Dr. Tseng performed an upper endoscopy and collected biopsies, revealing a Prague classification of C3M4, no hiatal hernia, and a diagnosis of non-dysplastic Barrett’s esophagus. Traditional – yet subjective – management based on these findings would be surveillance at a one-year interval.
When the TissueCypher results arrived, Dr. Tseng was concerned by the high-risk score and 14% probability of progression over 5 years. That prompted Dr. Tseng to have a discussion with the patient during which the prior diagnosis of EAC was revealed, and the patient agreed to move forward with radio-frequency ablation to remove his BE.
TissueCypher-guided management
Daniel Tseng, MD, FACS
